Free CE Course on GLP-1 RAs
Take advantage of a new free course from NPACE. Earn 1.0 CE credit for participating in the PCEC partner program, "Optimizing the Benefits of GLP-1 RAs in T2DM." This course is available until March 31st and must be completed by then to earn credit.
Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are an important element in the American Diabetes Association’s treatment algorithm for T2DM, yet they are under-prescribed. Learn about the benefits and limitations of GLP-1RAs and how they are making a difference in the lives of patients with T2DM.
Learning Objectives
At the end of the activity, participants will be able to:
- Compare the glycemic and extra-glycemic profile of GLP-1RAs with other classes of medications for type 2 diabetes mellitus.
- Contrast the similarities and differences among currently available GLP-1RAs.
- Select and optimize GLP-1RA therapy in collaboration with the patient to facilitate long-term patient self-management and adherence.
- Individualize GLP-1RA therapy for patients with T2DM and CV risk factors or established atherosclerotic cardiovascular disease as recommended by the ADA Standards of Medical Care in Diabetes - 2021.
|
